Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
Clinical trial NCT04530656 · COMPLETED
Trial details
- NCT number
- NCT04530656
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2020-10-28
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.